Stay updated on Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial
Sign up to get notified when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.

Latest updates to the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a minor update to the page’s documentation/versioning rather than a change to the study data itself.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, signaling a small update to the study record metadata.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page’s revision tag was updated from v3.6.0 to v3.6.2. This indicates a newer version of the page's metadata rather than a substantive change to the study details.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded a notice that the study is no longer looking for participants, clarifying that recruitment has ceased and potential participants should not enroll. The update also adds user-facing guidance sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and adjusts the Intervention/Treatment header formatting along with showing a new revision version (v3.6.0).SummaryDifference0.3%

- Check63 days agoChange DetectedThe page revision indicator was updated from v3.5.4 to v3.5.5, representing a new build of the ClinicalTrials.gov page. No trial content or data appear to be affected.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page now displays the revision label as v3.5.4, replacing the previous v3.5.3. This change signals a newer release of the site’s components and may reflect updates to the underlying platform used by the page.SummaryDifference0.0%

Stay in the know with updates to Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.